Perbedaan Merck Tbk. dan Multifiling Mitra Indonesia Tbk.: Merck Tbk. diperdagangkan di Rp3.900 (kapitalisasi pasar 1,76 T, volume 24 jam 63 rb), sedangkan Multifiling Mitra Indonesia Tbk. diperdagangkan di Rp1.300 (kapitalisasi pasar 984,86 M). Perbedaan utamanya: Merck Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| MERK | MFMI | |
|---|---|---|
Kapitalisasi Pasar | 1,76 T | 984,86 M |
Volume | 63 rb | — |
Lot | 630 | — |
Perputaran | 243,97 jt | — |
Harga Rata-rata | 3.872,46 | — |
Nilai Transaksi | 243,97 jt | — |
Harga Ekuilibrium Indikatif | 3.900 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Selengkapnya di halaman MFMI →